JACLYN HOUSEAL: Open Payments
NPI 1386338085 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Novo Nordisk Inc | 2 | $51 |
| ABBVIE INC. | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 4 | $44 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $16 |
Products named: AIRSUPRA, Rybelsus, VOQUEZNA, SHINGRIX, VRAYLAR, UBRELVY, Auvelity, PROQUAD.
Industry payments across IA — which companies pay providers there.
